Skip to main content
NCBI home page
The Canadian Veterinary Journal logoLink to The Canadian Veterinary Journal
. 1998 Mar;39(3):161–166.

A comparison of the clinical field efficacy and safety of florfenicol and tilmicosin for the treatment of undifferentiated bovine respiratory disease of cattle in western Canada.

B R Hoar 1, M D Jelinski 1, C S Ribble 1, E D Janzen 1, J C Johnson 1
PMCID: PMC1539941  PMID: 9524721

Abstract

We compared the field efficacy of a new antibiotic, florfenicol, with tilmicosin in the treatment of naturally occurring undifferentiated bovine respiratory disease. Beef calves with rectal temperatures greater than 40.5 degrees C and signs compatible with undifferentiated bovine respiratory disease were entered into the trial. Calves were randomly assigned to receive either florfenicol (20 mg/kg bodyweight intramuscularly; 2 injections 48 h apart) or tilmicosin (10 mg/kg bodyweight subcutaneously; 1 injection). Clinical measures of efficacy included mortality, rectal temperature, illness index score, assessment of treatment success or failure, and the number of relapses or reinfections. Performance was assessed based on weight gains from day 0 to day 90. Two hundred and twenty calves entered the trial; 112 received florfenicol and 108 received tilmicosin. Seventeen deaths occurred between day 0 and day 90, but only 10 during the 28-day trial period. Seven calves receiving tilmicosin died, compared with 3 receiving florfenicol (P = 0.20). Of the 220 initial treatments, 45 (20%) were categorized as treatment failures; 27 in the tilmicosin group and 18 in the florfenicol group (P = 0.10). The number of calves experiencing a 2nd relapse was significantly different, with 17 of 30 (57%) calves on tilmicosin compared with 7 of 26 (27%) calves on florfenicol relapsing at least twice (P = 0.02). Average daily gains over 90 days were 1.55 kg/day for florfenicol-treated calves and 1.51 kg/day for tilmicosin-treated calves. No significant adverse reactions were noticed with either drug. Results indicate that florfenicol and tilmicosin are comparable in the treatment of undifferentiated bovine respiratory disease in western Canada.

Full text

PDF
161

Images in this article

164Figure 2.
on p.164
164Figure 3.
on p.164

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams P. E., Varma K. J., Powers T. E., Lamendola J. F. Tissue concentrations and pharmacokinetics of florfenicol in male veal calves given repeated doses. Am J Vet Res. 1987 Dec;48(12):1725–1732. [PubMed] [Google Scholar]
  2. Allen J. W., Viel L., Bateman K. G., Rosendal S., Shewen P. E., Physick-Sheard P. The microbial flora of the respiratory tract in feedlot calves: associations between nasopharyngeal and bronchoalveolar lavage cultures. Can J Vet Res. 1991 Oct;55(4):341–346. [PMC free article] [PubMed] [Google Scholar]
  3. Camitta B. M., Storb R., Thomas E. D. Aplastic anemia (first of two parts): pathogenesis, diagnosis, treatment, and prognosis. N Engl J Med. 1982 Mar 18;306(11):645–652. doi: 10.1056/NEJM198203183061105. [DOI] [PubMed] [Google Scholar]
  4. Cannon M., Harford S., Davies J. A comparative study on the inhibitory actions of chloramphenicol, thiamphenicol and some fluorinated derivatives. J Antimicrob Chemother. 1990 Sep;26(3):307–317. doi: 10.1093/jac/26.3.307. [DOI] [PubMed] [Google Scholar]
  5. Gorham P. E., Carroll L. H., McAskill J. W., Watkins L. E., Ose E. E., Tonkinson L. V., Merrill J. K. Tilmicosin as a single injection treatment for respiratory disease of feedlot cattle. Can Vet J. 1990 Dec;31(12):826–829. [PMC free article] [PubMed] [Google Scholar]
  6. Harland R. J., Potter A. A., van Drunen-Littel-van den Hurk S., Van Donkersgoed J., Parker M. D., Zamb T. J., Janzen E. D. The effect of subunit or modified live bovine herpesvirus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves. Can Vet J. 1992 Nov;33(11):734–741. [PMC free article] [PubMed] [Google Scholar]
  7. Jim G. K., Booker C. W., Guichon P. T. A comparison of trimethoprim-sulfadoxine and ceftiofur sodium for the treatment of respiratory disease in feedlot calves. Can Vet J. 1992 Apr;33(4):245–250. [PMC free article] [PubMed] [Google Scholar]
  8. Kelly A. P., Janzen E. D. A review of morbidity and mortality rates and disease occurrence in north american feedlot cattle. Can Vet J. 1986 Dec;27(12):496–500. [PMC free article] [PubMed] [Google Scholar]
  9. Lobell R. D., Varma K. J., Johnson J. C., Sams R. A., Gerken D. F., Ashcraft S. M. Pharmacokinetics of florfenicol following intravenous and intramuscular doses to cattle. J Vet Pharmacol Ther. 1994 Aug;17(4):253–258. doi: 10.1111/j.1365-2885.1994.tb00241.x. [DOI] [PubMed] [Google Scholar]
  10. Magwood S. E., Barnum D. A., Thomson R. G. Nasal bacterial flora of calves in healthy and in pneumonia-prone herds. Can J Comp Med. 1969 Oct;33(4):237–243. [PMC free article] [PubMed] [Google Scholar]
  11. Mechor G. D., Jim G. K., Janzen E. D. Comparison of penicillin, oxytetracycline, and trimethoprim-sulfadoxine in the treatment of acute undifferentiated bovine respiratory disease. Can Vet J. 1988 May;29(5):438–443. [PMC free article] [PubMed] [Google Scholar]
  12. Morck D. W., Merrill J. K., Thorlakson B. E., Olson M. E., Tonkinson L. V., Costerton J. W. Prophylactic efficacy of tilmicosin for bovine respiratory tract disease. J Am Vet Med Assoc. 1993 Jan 15;202(2):273–277. [PubMed] [Google Scholar]
  13. Musser J., Mechor G. D., Gröhn Y. T., Dubovi E. J., Shin S. Comparison of tilmicosin with long-acting oxytetracycline for treatment of respiratory tract disease in calves. J Am Vet Med Assoc. 1996 Jan 1;208(1):102–106. [PubMed] [Google Scholar]
  14. Neu H. C., Fu K. P. In vitro activity of chloramphenicol and thiamphenicol analogs. Antimicrob Agents Chemother. 1980 Aug;18(2):311–316. doi: 10.1128/aac.18.2.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pazdernik T. L., Corbett M. D. Effects of chloramphenicol reduction products on hemopoietic precursor cells in vitro. Pharmacology. 1979;19(4):191–195. doi: 10.1159/000137309. [DOI] [PubMed] [Google Scholar]
  16. Shaw W. V. The problems of drug-resistant pathogenic bacteria. Comparative enzymology of chloramphenicol resistance. Ann N Y Acad Sci. 1971 Jun 11;182:234–242. doi: 10.1111/j.1749-6632.1971.tb30660.x. [DOI] [PubMed] [Google Scholar]
  17. Skolimowski I. M., Knight R. C., Edwards D. I. Molecular basis of chloramphenicol and thiamphenicol toxicity to DNA in vitro. J Antimicrob Chemother. 1983 Dec;12(6):535–542. doi: 10.1093/jac/12.6.535. [DOI] [PubMed] [Google Scholar]
  18. Syriopoulou V. P., Harding A. L., Goldmann D. A., Smith A. L. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother. 1981 Feb;19(2):294–297. doi: 10.1128/aac.19.2.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Van Donkersgoed J., Janzen E. D., Potter A. A., Harland R. J. The occurrence of Haemophilus somnus in feedlot calves and its control by postarrival prophylactic mass medication. Can Vet J. 1994 Sep;35(9):573–580. [PMC free article] [PubMed] [Google Scholar]
  20. Van Donkersgoed J. Meta-analysis of field trials of antimicrobial mass medication for prophylaxis of bovine respiratory disease in feedlot cattle. Can Vet J. 1992 Dec;33(12):786–795. [PMC free article] [PubMed] [Google Scholar]
  21. Watts J. L., Yancey R. J., Jr, Salmon S. A., Case C. A. A 4-year survey of antimicrobial susceptibility trends for isolates from cattle with bovine respiratory disease in North America. J Clin Microbiol. 1994 Mar;32(3):725–731. doi: 10.1128/jcm.32.3.725-731.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Yates W. D. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can J Comp Med. 1982 Jul;46(3):225–263. [PMC free article] [PubMed] [Google Scholar]
  23. Zaidenzaig Y., Fitton J. E., Packman L. C., Shaw W. V. Characterization and comparison of chloramphenicol acetyltransferase variants. Eur J Biochem. 1979 Oct 15;100(2):609–618. doi: 10.1111/j.1432-1033.1979.tb04208.x. [DOI] [PubMed] [Google Scholar]

Articles from The Canadian Veterinary Journal are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES